Minimize Uncertainty – Make Informed Decisions – Succeed

Vaccines

Vaccines Today—March 27, 2026

March 27, 2026Merck & Co.,Zaire Ebola Vaccine,pfizer,VLA15,BioPharma and Tech News,VAX-31,GeoVax,Barycela,SK Bioscience,SCB-1019,Lyme Disease,GEO-MVA,varicella,Centivax,Valneva,Universal Influenza Vaccine,Pneumococcal Disease,GC Biopharma,Vaccine news,Clover Biopharma,respiratory syncytial virusVaxcyte,IDT Biologika

This week’s Vaccines and Infectious Disease update highlights clinical trial…

by LucidQuest

Public_Health

Public Health Today—March 27, 2026

March 27, 2026Anesthesia and Brain Function,Prostate Cancer Treatment,BioPharma and Tech News,brain health,dementia risk,COVID-19 variants,Public Health News,Chronic inflammation,Physical activity,Severe Infections,Paternal Depression,Postpartum Mental Health,Colorectal Cancer Risk,Kidney Stone PreventionChronic Pain and Depression,Social Media and Mental Health

This weekly update in Public Health highlights new population-level research,…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—March 26, 2026

March 26, 2026Belief BioMed,BBM-H901,viral vectors,BBM-H803,Hemophilia A,Dalnacogene Ponparvovec,BioPharma and Tech News,Grand Life Sciences,hemophilia b,Etranacogene Dezaparvovec,Parkinson's Disease,Karmanos Cancer Institute,Ocugen,Cytiva,CSL Behring,Danaher Beacon,Hemgenix,Hematopoietic Stem Cells,Cell and Gene Therapy News,SK Pharmteco,SR Tiget,OCU410,Geographic atrophy,Sasineprocel,Aspen Neuroscience,Autologous Cell Therapy,Neuron replacement therapyOryon Cell Therapies,Age-related macular degeneration

This week’s Gene and Cell Therapy update highlights regulatory approvals,…

by LucidQuest

Rare Disease news

Rare Diseases Today—March 26, 2026

March 26, 2026Zorevunersen,Keratoconus,PANTHERx Rare,gsk,Dupixent,sanofi,Kygevvi,ucb,Thymidine kinase 2 deficiency,Duchenne Muscular Dystrophy,Pompe disease,BioPharma and Tech News,Sarepta Therapeutics,bullous pemphigoid,venglustat,Dupilumab,Gaucher Disease,Shionogi,Risvutatug Rezetecan,Biogen,AMONDYS 45,Dravet Syndrome,VYONDYS 53,Regeneron,S-606001,Small Cell Lung Cancer,Glaukos,Rare Disease News,OrsiniStoke Therapeutics,Epioxa

This week’s Rare Diseases update highlights regulatory designations, new…

by LucidQuest

Cardiovascular

Cardiovascular Today—March 26, 2026

March 26, 2026Corcym,Perceval Plus Lancelot,BioPharma and Tech News,Clarius,HEART FAILURE,T-Mode Heart,Medtronic,Heart Transplant,Cleveland Clinic,Invasive Fungal Infection,American Heart Association,Structural Heart,JenaValve,Cardiovascular News,Aortic regurgitation,Wolters Kluwer,University Health Network,OmniaSecure,DASI SimulationsPrecisionTAVI,Trilogy

This week’s Cardiovascular update highlights regulatory approvals, device…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: MSD to acquire Terns

March 26, 2026Oncology,clinical trials,market access,Regulatory,merck,hematology,biopharma,CML,Lucid Diligence Brief,diligence,M&A,Terns PharmaceuticalsTERN-701

Lucid Diligence Brief: MSD to acquire Terns Professional audiences only. Not…

by Timos Papagatsias

Neuroscience

Neuroscience Today—March 25, 2026

March 25, 2026CNSide,Apertura Gene Therapy,Our Insights,Viralgen,migraine,Akums Drugs & Pharmaceuticals,Alzheimer's Disease,Lasmiditan,roche,TfR1 CapX,BioPharma and Tech News,MIRA Pharmaceuticals,Plus Therapeutics,Mira-55,Neurotech International,Inflammatory Pain,Rett syndrome,Mankind Pharma,Neuroscience News,Rivotril,Anavex Life Sciences,Clonazepam,NTI164,Blarcamesine,Autism spectrum disorder,Brain Trauma FoundationLeptomeningeal metastases,Penetrating Traumatic Brain Injury,Central nervous system diseases

This week’s Neuroscience update highlights commercial launches, manufacturing…

by LucidQuest

Immunology

Immunology Today—March 25, 2026

March 25, 2026Cholestatic Pruritus,KT501,Ouro Medicines,Gamgertamig,Our Insights,OM336,SkinCure Oncology,gsk,Lynavoy,GentleBeam,sanofi,ICOTYDE,GentleCure,BioPharma and Tech News,Mindera Health,Nonmelanoma Skin Cancer,rheumatoid arthritis,Mountaineer Biosciences,Boehringer Ingelheim,Subtilitas,Plaque Psoriasis,Mabtech,Johnson & Johnson,Sai Life Sciences,Icotrokinra,EYRA,Gilead Sciences,Sonoma Pharmaceuticals,Immunology News,Persōn & Covey,primary biliary cholangitis,Aquanil AD,GalapagosCDR-Life,Linerixibat,Kali Therapeutics

This week’s Immunology update highlights regulatory progress, dermatology…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal

March 25, 2026biotech,drug development,merck,immunology,Ulcerative Colitis,IBD,Crohns Disease,Lucid Diligence Brief,diligence,platform biotech,Quotient Therapeutics,target discoverysomatic genomics

Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…

by Timos Papagatsias

Obesity Weekly News

Obesity Today—March 24, 2026

March 24, 2026Imcivree,wegovy,semaglutide,BioPharma and Tech News,obesity,Novo Nordisk,MetaVia,Setmelanotide,Obesity News,Biohaven,Rhythm Pharmaceuticals,Acquired Hypothalamic Obesity,Chronic Weight ManagementTaldefgrobep Alfa,DA-1726

This week’s Obesity update highlights regulatory progress, advancing clinical…

by LucidQuest

Endocrinology

Endocrinology Today—March 24, 2026

March 24, 2026GentiBio,GNTI-122,semaglutide,Endogenex,BioPharma and Tech News,Redcliffe Labs,Eli Lilly,Roche Diagnostics India,Acromegaly,Elecsys AMH Plus,Alexion,Paratek Pharmaceuticals,Crinetics,Radius Health,Endocrinology News,TYMLOS,Polycystic ovary syndrome,zydus lifesciences,retatrutide,Debiopharm,LupinEris Lifesciences,Natco Pharma

This week’s Endocrinology update highlights late-stage clinical progress,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines

March 24, 2026clinical trials,Regulatory,BCMA,immunology,Autoimmune Disease,Gilead,biopharma,Lucid Diligence Brief,payer access,diligence,T-cell engager,Ouro MedicinesOM336

Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines Professional…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.